Therefore, in current guideline-directed medical therapy related to the RAS, pharmacological blockade of this axis either by ACE inhibitors (ACEi) or AT1 receptor antagonists is the golden standard for the treatment of hypertension, HF and CKD [9–11]. The gene discussed is AGTR1; the disease is Hypertension.